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The Parvafox-nucleus in the lateral hypothalamus is characterized by the presence of two
distinct neural populations, the Parvalbumin (Parv) and the Foxb1-expressing ones. Foxb1-
neurons are born at day 10 in the subventricular zone of the mouse mammillary region. It
would be interesting to know if the subpopulation of Parv- neurons develop independently
at different times and then meet the Foxb1- expressing neurons in the lateral hypotha-
lamus, their ﬁnal settling place. The aim of this study was to deﬁne the period of birth of
the Parv-positive neurons using an in-vivo Bromodeoxyuridine-based method in rats. Parv-
neurons are generated from embryonic day 10 to day 13, with a peak at day 12. Thus, it
appears that the birthdates of the two subpopulations in these two species is similar,
perhaps suggesting that they are born from the same neuroepithelial region.
1. Introduction
The hypothalamus is known to play a pivotal role in the
regulation of vital functions (Dearden and Ozanne, 2015;
MacKay and Abizaid, 2014).
The Parvafox-nucleus is a cluster composed of two neu-
ronal populations, lodged within the ventrolateral hypotha-
lamus between the fornix and the optic tract, with axially-
located Parvalbumin (Parv)-positive neurons surrounded by a
cuff of Foxb1-expressing ones (Bilella et al., 2014; Celio, 1990).
In mice, the Foxb1-expressing neurons are generated in the
periventricular zone at embryonic day 10 and migrate tan-
gentially towards the ventrolateral hypothalamus between
the embryonic day 13 and 14 (Alvarez-Bolado et al., 2000).
Since 10% of the Parv-positive cells also express Foxb1 (Bilella
et al., 2014), they probably derive from the same source
during the same period of time. The period of birth and the
provenance of the remaining 90% Parv-neurons are unk-
nown. In this study, we used an in vivo Bromodeoxyuridine
(BrdU) method in order to deﬁne the temporal pattern of
genesis of the Parv-expressing neurons in Wistar rats. The
study revealed that the date of birth of these neurons was
between embryonic day 10 and embryonic day 13 with a peak
at embryonic day 12, similar to that of the Foxb1-expressing
neurons in mice (Alvarez-Bolado et al., 2000; Workman et al.,
2013).
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Horizontal sections through the Parvafox-nucleus of P18 rats
obtained from pregnant females injected on E6 to E14 were
analyzed by immunostaining for the presence of double
labeled Parv/BrdU cells.
BrdU positive nuclei were found on all examined sections
in different hypothalamic areas at all gestational days ana-
lyzed, but double labeled Parv/BrdU neurons in the Parvafox-
nucleus were observed only from E10 until E13 (Fig. 1). Only
few double positive cells started to appear at embryonic day
10 (E10, Fig. 1A). The number of the double stained nerve cells
in the Parvafox nucleus increases at E11 (Fig. 1B). A peak of
double-labeled neurons was observed at E12 (E12, Fig. 1C).
The number of neurons generated at E13 was again reduced
(Fig. 1D), and almost none were observed at E14 (not shown).
3. Discussion
Foxb1 is a winged helix transcription factor involved in the
development of the diencephalon during the embryogenesis
and to a lesser extent during the postnatal development
(Altman and Bayer, 1978; Alvarez-Bolado et al., 2000;
Croizier et al., 2014; Iball et al., 1966; Markakis and
Swanson, 1997; Szabo et al., 2015). Foxb1 is expressed in a
“patch” of the caudal hypothalamic neuroepithelium that
gives rise to neurons later forming deﬁned hypothalamic
nuclei. The Foxb1 pattern of expression evolves with time
with widespread expression in early stages of development
and very restricted one in the adult. Therefore, it is possible
to make a distinction between E9/E10, (Alvarez-Bolado et al.,
2000), when Foxb1 expressing neurons are born (Zhao et al.,
2008) and are conﬁned to the posterior hypothalamus and
E13/14 when Foxb1-expressing cells leave the mammillary
region andmigrate in rostral direction. They reach the tuberal
region of the lateral hypothalamus, giving rise to the Foxb1-
expressing neurons belonging to the Parvafox-nucleus
observed postnatally (Bilella et al., 2014). Of the total number
of neurons of the Parvafox-nucleus, 10% manifest double
staining for both Foxb1 and Parv- (Bilella et al., 2014), thereby
implying that these cells stem from the caudal periventricu-
lar zone (Alvarez-Bolado et al., 2000). Our study indicates that
in rats the Parv-positive cells are born ﬁrst around E10, their
number peaks at E12 and decreases at E13, conﬁrming what
was already observed for the Foxb1-neurons in mice (Alvarez-
Bolado et al., 2000; Szabó et al., 2015; Workman et al., 2013).
This is a time-interval in which the majority of the lateral
hypothalamic nerve cells are born (Croizier et al., 2014).
Indeed, the melanin-concentrating hormone (MCH) produ-
cing neurons, which form an abundant cell population wide-
spread in the diencephalon and also present in the lateral
hypothalamus show a similar spatio-temporal ontogeny also
peaking between E12 and E13 (although the MCH-expressing
neurons are generated throughout the entire time-period of
genesis of the whole hypothalamus, i.e. E10-E17) (Altman and
Bayer, 1978; Altman and Bayer, 1986; Amiot et al., 2005;
Brischoux et al., 2001; Khachaturian et al., 1985). The hypo-
cretin/orexin positive neurons in the lateral hypothalamus,
which are involved in the regulation of sleep/waking states
(Chemelli et al., 1999; Nishino et al., 2000; Peyron et al., 2000;
Thannickal et al., 2000) and feeding behavior (Qu et al., 1996;
Rossi et al., 1997), display also a similar ontogenic pattern.
These neurons are generated between the E11 and E14 with a
peak at E12 (Amiot et al., 2005). They start to express orexin
around E18 and complete the development during post-natal
stages (Steininger et al., 2004; Van Den Pol et al., 2001).
The Parvafox-nucleus is located in the most lateral portion
of the hypothalamus. According to the classical view of
hypothalamic ontogeny, the lateral part is laid down ﬁrst
(Altman and Bayer, 1986) and therefore would be expected to
show very early birthdates. However, the birthdate of the two
neural populations of the Parvafox coincides with the onto-
geny of lateral hypothalamic neurons situated at all medio-
lateral levels. This is in agreement with previous studies
(Alvarez-Bolado et al., 2012) showing that the postulated
“three waves” of hypothalamic neurogenesis (Altman and
Bayer, 1986) can be considered more a useful model than a
consistent description of all hypothalamic neurons.
4. Experimental procedures
4.1 Animals
Male and female Wistar rats, were used in the present study.
The animals were maintained on a 12-hour light/12-hour
dark cycle at a constant temperature of 24 1C and fed ad
libitum. The study was approved by the Fribourg Cantonal
Committee for Animal Experimentation.
The time of conception was documented by sperm-
positive vaginal smear examined on the morning following
the mating night (Embryonic day 0, E0) (Brischoux et al., 2001).
4.2 Bromodeoxyuridine injections
BrdU is a thymidine analog that is incorporated into the DNA
as 5-bromouracil during the S phase of the cell cycle of any
cells, and is widely used in vivo as a mitotic marker (Iball
et al., 1966). The BrdU method used in this study was similar
to that already described for the MCH neurons in the
hypothalamus (Brischoux et al., 2001).
Nine pregnant animals, from p.c. gestational day (E) 6, 7, 8,
9, 10, 11, 12, 13 and 14 (E6-E14) were given an i.p. injection of
5-bromo-2’-deoxyuridine (BrdU; Roche, Germany) 160 mg/Kg
body weight dissolved in 0.9% sterile NaCl, warmed to 60 1C
for complete solubilization and ﬁltered before injection
(Brischoux et al., 2001; Markakis and Swanson, 1997).
4.3 Immunohistochemistry
After being anaesthetized at postnatal day (P) 18 (Pentobarbi-
tal; 20 ml/10 g per body weight), two rats/injection time-point
(¼ total of 18 rats), constituting the progeny of the BrdU
injected mothers, were perfused ﬁrst with physiological
(0.9%) saline and then with chilled 4% paraformaldehyde
(4 1C) dilute in phosphate (0.1 M, pH7.3). The brains were
removed, immersed overnight in the same chemical ﬁxative,











Fig. 1 – Images of horizontal sections of the Parvafox-nucleus of progenies from pregnant females injected on embryonic day
10 (E10) to embryonic day 13 (E13), stained for BrdU and Parv. The insets show at higher magniﬁcation the results of merging
the Parv and BrdU staining; a single neuron, for each embryonic day is represented. Panels A, B, C, D show BrdU-staining
(red); panels A1, B1, C1, D1 show the Parv-staining (green), and panels A2, B2, C2, D2 show the merged images. White arrows
mark double labeled BrdU/Parv cells. A, A1, A2: BrdU-injection at E10. Only few cells are immunopositive for both BrdU and
Parv (A2), while the Parvafox nucleus already contains numerous Parv-postive BrdU-negative cells (A1). B, B1, B2: BrdU
injection at E11. BrdU staining is more widespread through the lateral hypothalamus compared to E10 (A). Nevertheless, only
few Parv-positive cells in the Parvafox are also BrdU-immunoreactive (B2). C, C1, C2: BrdU injection at E12. BrdU labeled cells
are visible throughout the ventral hypothalamus. Most of the Parv-positive neurons of the Parvafox nucleus show BrdU
immunoreactivity. D, D1, D2: BrdU injection at E13. E13 marks the cessation of the generation of Parv-positive cells, as only











phosphate (0.1 M) – buffered sucrose, for cryoprotection.
Horizontal, 40 mm-thick cryo-sections were prepared using a
freezing microtome (Frigomobil Reichert-Jung, Vienna, Aus-
tria) and collected in 0.1 M phosphate buffer (pH 7.3). Free-
ﬂoating sections were treated for 1 day at room temperature
with a monoclonal antibody against parvalbumin (PV 235
(Swant, Marly, Switzerland) diluted 1:1’000 in TBSþ10%
bovine serum) and then with an anti-mouse Alexa 488 anti-
body (Jackson ImmunoResearch, Laboratories, INC, USA)
diluted 1:500 in Tris–HCl (pH 8.2). Cell nuclei were revealed
by counterstaining with DAPI (diluted 1:2’000 in phosphate-
buffered saline) for 5 minutes at room temperature. After-
wards, the sections were mounted on glass slides, treated for
30 min at 37 1C in 2NHCl followed by rinsing in 0.1 M borate
buffer pH8.5, and then exposed for 1 day at room temperature
(RT) to a rat anti-BrdU antiserum (Abcam, Cambridge Science
Park Cambridge CB4 0FL UK, diluted 1:200 in TBSþ0.2%
Triton-X 100þ10% bovine serum). The sections were rinsed
in TBS and then incubated for 2 hours at room temperature
with biotinylated goat anti-rat antibody (Vector Laboratories,
Burlingame, CA, USA, diluted 1:200 in TBSþ10% bovine
serum). After rinsing once in TBS and twice in Tris–HCl (pH
8.2), the sections were exposed for 2 hours to Cy3-conjugated
streptavidin (Jackson ImmunoResearch, Laboratories, INC,
USA) diluted 1:200 in Tris–HCl (pH 8.2).
The sections were evaluated with either a Leica 6’000
epiﬂuorescence microscope (equipped with a Hamamatsu
C4742-95 camera), a digital slide scanner (Nanozoomer,
Hamamatsu) or a Leica TCS SP5 confocal laser microscope.
Images were post-processed for brightness and contrast
using Adobe Photoshop CS5. The image stacks were prepared
with ImageJ 1.44p software and the ﬁgures collated using the
Adobe Illustrator CS6.
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